Mounjaro & Wegovy Safety Guide for Click Counting & Using Pens Beyond 4 Weeks
Navigating your GLP-1 treatment shouldn't be stressful. If you are wondering about the safety of click counting or whether it is safe to use your pen beyond the 4-week mark, this guide is for you. In this video, I provide a comprehensive safety breakdown and a live, side-by-side demonstration of both the Mounjaro and Wegovy devices. In this video, you will learn: The truth about using pens beyond 4 weeks. Essential safety protocols when switching between devices. A step-by-step masterclass on accurate click counting to ensure precise dosing. Timestamps: 0:00 - Safety & Duration: The 4-Week Guideline 7:00 - Practical Demonstration: Mounjaro vs. Wegovy Pen Techniques Disclaimer: This video is for educational purposes only. Always consult your healthcare provider for personalized advice regarding your medication.
Should Everyone Take GLP-1s? (What Changed My Mind)
GLP-1s 7X More Likely to Keep the Weight Off? The New Data Is Stunning
Ozempic Constipation: Why It Happens and Exactly How to Fix It (Weight Loss Doctor Explains)
Forget Zepbound: 15 New Obesity Drugs Are Coming
Ozempic & Mounjaro: Same Shot. Opposite Results.
Doctor Explains How To PREVENT Ozempic Face (don’t ignore)
I’m a Pathologist: The "Biological Cost" of Ozempic and Mounjaro.
Starting a GLP-1? Listen to This BEFORE You Start
DO THIS To DOUBLE Your GLP-1 Results to MAXIMIZE Weight Loss
(Dr Explains) 8 Signs You're Taking Too Much Ozempic, Mounjaro, or Zepbound!
What is OZEMPIC, WEGOVY & SEMAGLUTIDE and how do they WORK?
Tapering Off GLP-1s Like Wegovy & Zepbound: A Clinical Perspective
How Do Ozempic, Mounjaro & Other GPL-1 Agonists Work? | Dr. Zachary Knight & Dr. Andrew Huberman
RETATRUTIDE VS. TIRZEPATIDE: Which is Better for Weight Loss After 40? (Doctor Breaks It Down) |
The Big GLP-1 Debate: What the Science ACTUALLY Says
No Seriously, This New Drug Just Changed Fat Loss Forever. (Doctor Explains)
The 10 Best Foods That Make Ozempic & Zepbound Work FASTER! Weight Loss Doctor Explains
Most People Get GLP-1 Wrong: Here's What Works
1 in 4 Have a Tirzepatide Advantage! Downsized News
